Thrivent Financial for Lutherans Trims Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Thrivent Financial for Lutherans reduced its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 330,948 shares of the medical equipment provider’s stock after selling 49,528 shares during the period. Thrivent Financial for Lutherans owned about 0.09% of Intuitive Surgical worth $172,955,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. PDS Planning Inc grew its holdings in Intuitive Surgical by 3.8% during the fourth quarter. PDS Planning Inc now owns 1,385 shares of the medical equipment provider’s stock worth $723,000 after acquiring an additional 51 shares during the period. Haven Capital Group Inc. purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $3,221,000. Petra Financial Advisors Inc. acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $208,000. BlackDiamond Wealth Management LLC increased its holdings in shares of Intuitive Surgical by 3.5% during the 4th quarter. BlackDiamond Wealth Management LLC now owns 615 shares of the medical equipment provider’s stock valued at $321,000 after purchasing an additional 21 shares in the last quarter. Finally, Cassady Schiller Wealth Management LLC lifted its stake in shares of Intuitive Surgical by 1.6% in the 4th quarter. Cassady Schiller Wealth Management LLC now owns 1,539 shares of the medical equipment provider’s stock valued at $803,000 after purchasing an additional 24 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock valued at $17,691,621 in the last three months. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $488.80 on Tuesday. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The stock has a market cap of $174.10 billion, a PE ratio of 76.26, a P/E/G ratio of 5.85 and a beta of 1.43. The stock has a 50 day moving average price of $566.38 and a 200 day moving average price of $531.96.

Wall Street Analyst Weigh In

ISRG has been the topic of several analyst reports. Stifel Nicolaus raised their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. Leerink Partners raised their target price on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Truist Financial cut their price target on Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating for the company in a research note on Monday. Wells Fargo & Company increased their price target on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Finally, CICC Research began coverage on Intuitive Surgical in a research report on Monday, January 27th. They issued a “neutral” rating and a $550.00 price objective for the company. One analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $610.19.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.